To study the effects of 3-n-butylphthalide (NBP) on the TREK-1 channel expressed in Chinese hamster ovary (CHO) cells. Methods: Whole-cell patch-clamp recording was used to record TREK-1 channel currents. The effects of varying doses of l-NBP on TREK-1 currents were also observed. Current-clamp recordings were performed to measure the resting membrane potential in TREK-1-transfected CHO (TREK-1/CHO) and wild-type CHO (Wt/CHO) cells. Results: l-NBP (0.01-10 μmol/L) showed concentration-dependent inhibition on TREK-1 currents (IC 50 =0.06±0.03 μmol/L), with a maximum current reduction of 70% at a concentration of 10 μmol/L. l-NBP showed a more potent inhibition on TREK-1 current than d-NBP or dl-NBP. This effect was partially reversed upon washout and was not voltage-dependent. l-NBP 10 μmol/L elevated the membrane potential in TREK-1/CHO cells from -55.3 mV to -42.9 mV. However, it had no effect on the membrane potential of Wt/CHO cells. Conclusion: l-NBP potently inhibited TREK-1 current and elevated the membrane potential, which may contribute to its neuroprotective activity.
Introduction
Two-pore-domain potassium (K2P) channels are a novel family of potassium channels with four transmembrane segments and two pore-forming domains located in tandem [1, 2] . These channels control neuronal excitability through their influence on resting membrane potential (RMP). Thus, they are classified as background potassium channels or leak potassium channels [3, 4] . To date, 17 human K2P channel subunits have been identified according to their amino acid sequence identity and regulatory mechanisms. They can be divided into six subfamilies: TWIK, THIK, TASK, TALK, TREK, and TRESK [5, 6] . TREK-1 is one of the most important members of the K2P channel family and is expressed throughout the central nervous system (CNS) [4, 7] . In addition to its unusual gating properties, such as background channel activity and sensitivity to membrane stretch, the TREK-1 channel can be modulated by many different intracellular and extracellular chemical agents.
For example, TREK-1 is activated by increased temperature, membrane stretch and internal acidosis and is also sensitive to the presence of some polyunsaturated fatty acids [such as arachidonic acid (AA)] and gaseous general anesthetics (such as halothane and nitrous oxide) [8] [9] [10] [11] . It has been recently reported that the TREK-1 channel is also modulated by neuroprotective agents such as riluzole and plays an important role in neuroprotection [12, 13] . In our previous studies, we showed that the expression of TREK-1 mRNA and protein significantly increased after acute and chronic cerebral ischemia, suggesting that the TREK-1 channel may be closely linked to pathological conditions such as cerebral ischemia [14, 15] . 3-n-Butylphthalide (NBP) is a potent neuroprotectant that was approved by the State Food and Drug Administration (SFDA) of China at the end of 2002 as a new drug for the treatment of ischemic stroke [16] . Pre-clinical and clinical studies have demonstrated that racemic NBP (dl-NBP) is a promising drug for the treatment of ischemic stroke. This neuroprotectant influences several pathophysiological processes such as improving rat brain microcirculation, inhibiting platelet aggregation, preventing oxidative damage from ischemia and reducing Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1 www.chinaphar.com Ji XC et al Acta Pharmacologica Sinica npg neuronal apoptosis [17] [18] [19] [20] [21] . However, the molecular mechanisms underlying the actions of dl-NBP remain unclear. Recently, we have found that the optical isomer l-NBP is more potent in terms of neuronal protection against ischemic stroke than dl-NBP [16] . This study aimed to compare the effect of dl-NBP and its optical isomers on the TREK-1 channel and to further elucidate the mechanism of the protective effects of l-NBP against ischemia.
Materials and methods
Materials l-NBP, dl-NBP, and d-NBP (purity >99%) ( Figure 1A) were provided by the Department of Medical Synthetic Chemistry, Institute of Materia Medica. HEPES, EGTA, Na 2 ATP, AA, penicillin G, and streptomycin sulfate were purchased from Sigma Chemical Co (St Louis, MO, USA); Dulbecco's modified Eagle's medium (DMEM), trypsin and G418 were purchased from GibcoBRL (Gaithersburg, MD, USA). Other reagents were provided by Beijing Chemical Company (Beijing, China).
Cell culture A stable cell line of wild-type Chinese hamster ovary (Wt/ CHO) cells expressing rat TREK-1 channels was maintained in culture medium (DMEM) supplemented with 10% (v/v) heatinactivated fetal bovine serum, 100 µg/mL penicillin G and 100 µg/mL streptomycin sulfate in a humidified incubator with an atmosphere of 95% air and 5% CO 2 at 37 °C. G418 was added into the culture medium to select for transfected cells. When the cells were 80% confluent, they were split and plated onto 35-mm culture dishes. The cells were assayed 24 h later.
Electrophysiology and drug application
Membrane currents were recorded using a whole-cell voltageclamp configuration. Recording glass pipettes had a resistance of 3-5 MΩ. The external solution contained the following (in mmol/L): NaCl, 150; KCl, 5.4; MgCl 2 , 2; CaCl 2 , 1.2; glucose, 15; and HEPES, 5 (titrated to pH 7.4 with NaOH). The patchpipette solution contained the following (in mmol/L): KCl, 140; MgCl 2 , 0.5; EGTA, 10; and HEPES, 10 (titrated to pH 7.2 with KOH). Currents were evoked in response to voltage ramps, and voltage steps were generated using an EPC-10 patch-clamp amplifier (HEKA Electronics, Lambrecht, Germany), filtered at 2.9 kHz, digitized at 10 kHz and stored on a computer. Data were analyzed using Pulse 8.6 software (HEKA Electronics, Lambrecht, Germany). Before seal formation, the voltage offset between the patch electrode and the bath solution was adjusted to produce zero current. After seal formation (≥1 GΩ) and membrane rupturing, the cells were allowed to stabilize for approximately 5 min. The holding potential during experiments was set at -80 mV. All electrophysiological measurements were carried out at room temperature (23-25 °C).
Data analysis and statistics
All data were analyzed using Pulsefit 8.6 (HEKA Electronics, Lambrecht, Germany) and MicroCal Origin software and are expressed as means±SEM. For dose-response experiments, current amplitudes at +60 mV in the presence and absence of NBP were measured by evoking the currents with a ramp pulse protocol from -80 mV to +60 mV over 400 ms. To obtain concentration-response curves, the percent inhibition of the current by NBP was quantified at various test concentrations according to the following equation: percent inhibition=100(1-I drug /I control ). The current density of TREK-1 was calculated by dividing the current by the whole-cell capacitance (expressed in pA/pF). Significant differences between groups were assessed by unpaired Student's t-test and one-way analysis of variance (ANOVA). The criterion for significance was P<0.05 in all analyses. n values indicate the number of experiments performed.
Results

Electrophysiological properties of TREK-1 channels
Under the current-clamp configuration, the RMPs of Wt/CHO and TREK-1/CHO cells were -17.6±4.0 mV (n=7) and -55.3±2.4 mV (n=25), respectively ( Figure 1B) . A large, depolarizing voltage step from -80 mV to +80 mV evoked a dramatic, outward, non-inactivating current in TREK-1/CHO cells but not in Wt/CHO cells ( Figure 1C ). We also found that 10 μmol/L AA increased TREK-1 current by 60.0%±3.6% (n=6) ( Figure  1Cc ). These results are consistent with previous reports regarding the properties of TREK-1 channels [22] .
Effect of NBP isomers on TREK-1 channel currents
To investigate whether dl-NBP isoforms modulate transfected TREK-1 channels, we exposed TREK-1/CHO cells to dl-NBP and its optical isomers after a 5-min control period and then washed out the drugs with the control solution. TREK-1 currents were evoked by a ramp protocol from a holding potential of -80 mV to +60 mV over 400 ms. A typical control current is shown in Figure 2A , and a comparison of the inhibitory effects of NBP isoforms at +60 mV is shown in Figure 2B (P<0.05). We found that 10 μmol/L of l-NBP, dl-NBP, and d-NBP inhibited the current by 70.0%±2.0% (n=8), 50.9%±4.8% (n=9) and 55.8%±3.4% (n=9), respectively. Current inhibition was not caused by rundown, which was less than 10% over a 20-min period. This result indicates that l-NBP is much more potent than dl-and d-NBP in the inhibition of TREK-1 currents. Therefore, we focused on l-NBP alone for the remainder of the study. The inhibitory effects of NBP isomers on TREK-1 currents were partially reversed upon washout.
l-NBP inhibited TREK-1 channel currents in a dose-dependent manner We elicited TREK-1 currents with depolarizing voltage steps from a holding potential of -80 mV ( Figure 3A) . l-NBPmediated inhibition of TREK-1 currents was partially reversed upon washout. This inhibition was concentration dependent over the range of 0.01 to 10 μmol/L. The maximum inhibition of TREK-1 current by l-NBP (70.0%±2.0%, n=8) was observed at a concentration of 10 μmol/L ( Figure 3B ). This dose-dependent response was well fitted to the Figure  3C shows the current-voltage relationship (I-V) curve for the inhibition of TREK-1 channels by 0.3 μmol/L l-NBP. The inhibition was gradual and usually reached a peak 3-5 min after l-NBP exposure. Whole-cell current density was normalized to control currents, and the voltage dependence of the block- Figure 3D ). The inhibition did not change substantially between -80 mV and +80 mV, indicating a lack of voltage dependence for the effect of l-NBP. This effect was partially reversed upon washout.
Effects of l-NBP on the membrane potential of TREK-1/CHO cells Inhibition of TREK-1 channels has been reported to depolarize the cell membrane [7, 12] . Therefore, we compared the effects 
Discussion
Two-pore-domain potassium channels form a novel class of K + channels identified in various types of neurons [23, 24] . They are open when membrane potentials are in the physiological range and are therefore likely to contribute to background or leak currents. They are also crucial in shaping neuronal excitability by regulating the RMP. The TREK-1 channel is an important member of the K2P family and is expressed throughout the CNS. The TREK-1 channel is voltage independent and is not inactivated [25] . TREK-1 has been previously reported to play an important role in neuroprotection against acid pathological condi tions [4, 7, 12, 26] . In electrophysiological studies, some lipids substantially increase the probability of these K2P channels being open, thus hyperpolarizing the membrane potential and reducing neuronal excitability [12, [27] [28] [29] [30] . This action on the part of lipids would be predicted to counteract the neuronal damage that arises from the increased membrane excitability that often accompanies CNS insults such as ischemia. A link between TREK-1 and neuroprotection, although a highly attractive hypothesis, has not been unequivocally demonstrated, mainly due to the lack of selective K2P antago nists [13, 31] . In this study, we demonstrated that NBP, a neuroprotective agent, potently inhibited the TREK-1 channel expressed in CHO cells in a concentration-dependent manner. This study is the first description of the inhibition of TREK-1 by NBP, and this property may underlie its beneficial neuroprotective activity [31] . Moreover, the inhibition of TREK-1 currents by l-NBP was more significant than that by d-and dl-NBP. Therefore, the optical activity of NBP may have a close relationship with its biological activities.
Our data stand somewhat in contrast to the neuroprotection reported for TREK-1 facilitators, such as unsaturated fatty acids, riluzole and volatile anesthetics. Thus, although TREK-1 potentiation may be neuroprotective, our data also suggest that the inhibition of these channels may yield significant cell protection, similar to the effects of the neuroprotective agent sipatrigine on TREK-1 channels [31] . It is well known that K2P channels can modulate the RMP and that their activity may regulate cell excitability. K2P antagonism would produce depolarization and increased membrane excitability, which may induce or enhance neuronal damage. However, recent studies have shown that the regulation of K2P channels may be complex under pathological conditions [12, 32] . As reported by Meadows et al [31] , TREK-1 antagonism produced greater changes in the excitability of inhibitory neurons than their excitatory counterparts. An increase in inhibitory tone could represent a neuroprotective mechanism. Furthermore, some immunohistochemical studies indicate that TREK-1 is predominantly expressed in GABAergic interneurons of the hippocampus, isocortex, thalamus and cerebellum [7, 28, 33, 34] . Decreasing glutamate release is a widely accepted neuroprotective strategy and is also a previously well-demonstrated activity of NBP [18, 31] . Thus, one potential mechanism of K2P inhibition-related neuroprotection would occur through an increase in glutamate uptake by astrocytes. It has been demonstrated that TREK-1 is expressed in astrocytes, and the activators of TREK-1, including arachidonic acid and chloroform, significantly attenuate glutamate uptake by astrocytes [35] [36] [37] . Therefore, l-NBP-mediated inhibition of TREK-1 channels may help to maintain or increase the function of glutamate uptake by astrocytes during brain ischemia. Furthermore, the TREK-1 channel is known to be an O 2 -sensitive K + channel, and acute hypoxia can occlude its activation by AA and other activators [38, 39] . This finding suggests that TREK-1 may not be activated during systemic hypoxia (as occurs during cerebral ischemia). Therefore, it is difficult to explain the role of TREK-1 in neuroprotection. One possibility is that this property may depend on the expression pattern of TREK-1 [31, 38, 40, 41] . Further investigation into the role of TREK-1 in neuronal damage/protection is needed.
In summary, this study demonstrated that NBP (and especially l-NBP), a novel neuroprotective agent, potently inhibits TREK-1 channels. The inhibition of TREK-1 channels results in the depolarization of the cell membrane. We suggest that the effects of NBP on TREK-1 channels are closely related to its neuroprotective role. TREK-1 channels may represent a target for NBP in treatment of cerebral ischemia and neurodegenerative diseases. However, the mechanism of protection of neurons via TREK-1 inhibition by NBP requires further study.
